| Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer A Prat, JS Parker, O Karginova, C Fan, C Livasy, JI Herschkowitz, X He, ... Breast cancer research 12, 1-18, 2010 | 2876 | 2010 |
| Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors JI Herschkowitz, K Simin, VJ Weigman, I Mikaelian, J Usary, Z Hu, ... Genome biology 8, 1-17, 2007 | 1710 | 2007 |
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ... Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009 | 1638 | 2009 |
| Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes JH Taube, JI Herschkowitz, K Komurov, AY Zhou, S Gupta, J Yang, ... Proceedings of the National Academy of Sciences 107 (35), 15449-15454, 2010 | 1223 | 2010 |
| The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo KL Meerbrey, G Hu, JD Kessler, K Roarty, MZ Li, JE Fang, JI Herschkowitz, ... Proceedings of the National Academy of Sciences 108 (9), 3665-3670, 2011 | 734 | 2011 |
| FOXC2 expression links epithelial–mesenchymal transition and stem cell properties in breast cancer BG Hollier, AA Tinnirello, SJ Werden, KW Evans, JH Taube, TR Sarkar, ... Cancer research 73 (6), 1981-1992, 2013 | 325 | 2013 |
| The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas JI Herschkowitz, X He, C Fan, CM Perou Breast Cancer Research 10, 1-13, 2008 | 304 | 2008 |
| Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ... Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012 | 258 | 2012 |
| Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts AD Pfefferle, JI Herschkowitz, J Usary, JC Harrell, BT Spike, JR Adams, ... Genome biology 14, 1-16, 2013 | 252 | 2013 |
| Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation T Welte, IS Kim, L Tian, X Gao, H Wang, J Li, XB Holdman, ... Nature cell biology 18 (6), 632-644, 2016 | 206 | 2016 |
| Gene expression patterns associated with p53 status in breast cancer MA Troester, JI Herschkowitz, DS Oh, X He, KA Hoadley, CS Barbier, ... BMC cancer 6, 1-13, 2006 | 201 | 2006 |
| Characterization of mammary tumors from Brg1 heterozygous mice SJ Bultman, JI Herschkowitz, V Godfrey, TC Gebuhr, M Yaniv, CM Perou, ... Oncogene 27 (4), 460-468, 2008 | 187 | 2008 |
| Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status Z Jiang, T Deng, R Jones, H Li, JI Herschkowitz, JC Liu, VJ Weigman, ... The Journal of clinical investigation 120 (9), 3296-3309, 2010 | 165 | 2010 |
| ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex Z Li, CE Tognon, FJ Godinho, L Yasaitis, H Hock, JI Herschkowitz, ... Cancer cell 12 (6), 542-558, 2007 | 156 | 2007 |
| Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties JH Taube, GG Malouf, E Lu, N Sphyris, V Vijay, PP Ramachandran, ... Scientific reports 3 (1), 2687, 2013 | 147 | 2013 |
| RB1 and p53 at the crossroad of EMT and triple-negative breast cancer Z Jiang, R Jones, JC Liu, T Deng, T Robinson, PED Chung, S Wang, ... Cell cycle 10 (10), 1563-1570, 2011 | 128 | 2011 |
| c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer R Nair, DL Roden, WS Teo, A McFarland, S Junankar, S Ye, A Nguyen, ... Oncogene 33 (30), 3992-4002, 2014 | 115 | 2014 |
| The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer SB Greene, JI Herschkowitz, JM Rosen RNA biology 7 (3), 300-304, 2010 | 98 | 2010 |
| Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer JF Knight, R Lesurf, H Zhao, D Pinnaduwage, RR Davis, SMI Saleh, ... Proceedings of the National Academy of Sciences 110 (14), E1301-E1310, 2013 | 96 | 2013 |
| BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development F Bai, HL Chan, A Scott, MD Smith, C Fan, JI Herschkowitz, CM Perou, ... Cancer research 74 (21), 6161-6172, 2014 | 87 | 2014 |
Jeffrey M RosenProfessor of Molecular & Cellular Biology, Baylor College of MedicineEmail verificata su bcm.edu